Cell surface Glut1 levels distinguish human CD4 and CD8 T lymphocyte subsets with distinct effector functions
April 12, 2016
Attending the first European Conference on Glut1 Deficiency
October 7, 2016
April 16, 2016.
[NEWS] Company
In this interview, lead by BFM Business Radio, METAFORA’s CEO Vincent Petit discusses the company’s participation in the prestigious BigBooster program, an initiative that supports the international development of pioneering French tech startups.
Through Big Booster, METAFORA was able to take part in two intensive bootcamp programs – one held in Boston, Massachusetts and another in Lyon, France. These immersive experiences provided the company with invaluable opportunities to engage with a diverse array of stakeholders, including investors, industry leaders, key opinion leaders, doctors, and communications experts.
METAFORA’s groundbreaking innovation allows for the early identification of a cell’s precise nutritional needs by assessing its metabolic fitness. This transformative technology enables the detection of whether a cell is in a healthy or pathological state, paving the way for more accurate diagnosis and treatment of various diseases.
Hear from Vincent Petit as he shares how METAFORA’s involvement in the BigBooster program has bolstered the company’s ambitions for global expansion.
